You are here: Industry Insights > Omicron variant

News List

People may need another COVID-19 vaccine booster shot in fall of 2022: Moderna CEO ExpressPharma
January 10, 2022
The efficacy of boosters against COVID-19 is likely to decline over the next few months, and people may need another shot in the fall of 2022, Stephane Bancel...
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine prnewswire
January 05, 2022
Thermal Custom Packaging (TCP), a company specializing in transportation solutions for sensitive healthcare and military cargo, is bringing its packaging to the front lines of the COVID vaccine distribution...
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study WorldPharmaNews
December 20, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralising activity against the Omicron SARS-CoV-2 variant (B.1.1.529), according to new preclinical data.
SAB Biotherapeutics’ SAB-185 shows activity against Omicron variant in study Pharmaceutical-Technology
December 20, 2021
SAB Biotherapeutics has reported that its antibody SAB-185 for Covid-19 retained neutralisation activity against the Omicron variant of SARS-CoV-2 in an in vitro pseudovirus model.
Evusheld Long-Acting Antibody Combination Retains Neutralizing Activity Against Omicron Variant in Independent FDA Study AmericanPharmaceuticalReview
December 17, 2021
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron SARS-CoV-2 variant (B.1.1.529), according to new preclinical data.
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube prnasia
December 10, 2021
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape.
Anixa Biosciences, MolGenie Find COVID Compounds Effective Against Omicron contractpharma
December 08, 2021
Results of a genomic variant analysis indicate that the compounds in development should be effective against the Omicron variant.
Next virus could be more lethal than COVID-19, warns Oxford vaccine creator PharmaTimes
December 07, 2021
With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve.
NIHR study shows high efficacy of booster vaccines PharmaTimes
December 06, 2021
The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has no previous connection to the previous nine.

Previous page 1 2 Next page